JP Morgan analyst David Low downgrades ResMed (NYSE:RMD) from Overweight to Neutral.
Jim Cramer Says This Construction Giant Is ‘So Good’ And ‘Goes Higher’
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying The Allstate Corporation (NYSE: ALL), which recently posted upbeat results for its fourth quarter.
